Skip to main content

Table 2 Summary of case history findings (N = 50)

From: Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa

Patient Complaints Baseline Mid-cycle 1-month post-treatment p-value
Repeated Ear infections 2 (4) 2 (4) 2 (4) 0.988
 Bilateral 0 0 0
 Left ear only 1 (50) 1 (50) 1 (50)
 Right 1 (50) 1 (50) 1 (50)
Reduced hearing 7 (14) 8 (16) 11 (22) 0.36
 Bilateral 4 (57.1) 5 (62.5) 5 (45.4)
 Left ear only 1 (14.3) 1 (12.5) 3 (27.3)
 Right ear only 2 (28.6) 2 (25) 3 (27.3)
Otalgia 3 (6) 8 (16) 5 (10) 0.52
Tinnitus 21 (42) 26 (52) 17 (34) 0.42
 Bilateral 10 (47.6) 14 (53.9) 11 (64.7)
 Left ear only 8 (38.1) 7 (26.9) 1 (5.9)
 Right ear only 1 (4.8) 3 (11.5) 4 (23.5)
 Head 2 (9.5) 2 (7.7) 1 (5.9)
  1. *Cochran-Armitage test for a linear trend in proportions